Viewing Study NCT00372892


Ignite Creation Date: 2025-12-24 @ 3:51 PM
Ignite Modification Date: 2026-02-24 @ 2:29 PM
Study NCT ID: NCT00372892
Status: COMPLETED
Last Update Posted: 2012-06-07
First Post: 2006-09-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP)
Sponsor: Hamilton Health Sciences Corporation
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Purpura, Thrombocytopenic, Idiopathic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Feasibility study View
None Idiopathic Thrombocytopenic Purpura View
None Rituximab View